Tumour necrosis factor-α inhibitors have a growing role in managing late-onset ankylosing spondylitis and spondylarthritis

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite

Structure-Modifying Capacity of Anti-Tumour Necrosis Factor- Therapy in Ankylosing Spondylitis

By Filip De Keyser   Baeten Dominique   Filip Van den Bosch   Kruithof Elli   Verbruggen Gust   Mielants Herman   Veys Eric  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2793-2811

Adis International

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies: Update on Safety in Older Patients

By Ornetti Paul   Chevillotte Hélène   Zerrak Amal   Jean Francis Maillefert  

Drugs & Aging, Vol. 23, Iss. 11, 2006-01 ,pp. : 855-860

Adis International

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Levels in Non-diabetic Offspring of Patients with Type 2 Diabetes Mellitus

By Maltezos E   Papazoglou D   Exiara T   Papazoglou L   Karathanasis E   Christakidis D   Ktenidou-Kartali S  

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 576-583

Field House Publishing

Access to resources Recommend Favorite

Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

By Smith Jeannina A.   Kauffman Carol A.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1403-1415

Adis International

Access to resources Recommend Favorite